RYOIX vs. RMQAX
Compare and contrast key facts about Rydex Biotechnology Fund (RYOIX) and Rydex Monthly Rebalance NASDAQ-100 2x Strategy Fund (RMQAX).
RYOIX is managed by Rydex Funds. It was launched on Mar 31, 1998. RMQAX is managed by Rydex Funds. It was launched on Nov 27, 2014.
Performance
RYOIX vs. RMQAX - Performance Comparison
Loading graphics...
RYOIX vs. RMQAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RYOIX Rydex Biotechnology Fund | -2.83% | 30.62% | -0.95% | 6.06% | -13.04% | 2.05% | 21.94% | 30.69% | -8.94% | 29.68% |
RMQAX Rydex Monthly Rebalance NASDAQ-100 2x Strategy Fund | -19.02% | 33.92% | 44.76% | 115.91% | -59.93% | 56.36% | 101.06% | 80.80% | -7.28% | 69.80% |
Returns By Period
In the year-to-date period, RYOIX achieves a -2.83% return, which is significantly higher than RMQAX's -19.02% return. Over the past 10 years, RYOIX has underperformed RMQAX with an annualized return of 8.46%, while RMQAX has yielded a comparatively higher 30.14% annualized return.
RYOIX
- 1D
- 1.00%
- 1M
- -6.92%
- YTD
- -2.83%
- 6M
- 11.88%
- 1Y
- 28.65%
- 3Y*
- 10.88%
- 5Y*
- 3.74%
- 10Y*
- 8.46%
RMQAX
- 1D
- -1.68%
- 1M
- -16.37%
- YTD
- -19.02%
- 6M
- -16.53%
- 1Y
- 31.63%
- 3Y*
- 33.85%
- 5Y*
- 15.55%
- 10Y*
- 30.14%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
RYOIX vs. RMQAX - Expense Ratio Comparison
RYOIX has a 1.36% expense ratio, which is higher than RMQAX's 1.32% expense ratio.
Return for Risk
RYOIX vs. RMQAX — Risk / Return Rank
RYOIX
RMQAX
RYOIX vs. RMQAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rydex Biotechnology Fund (RYOIX) and Rydex Monthly Rebalance NASDAQ-100 2x Strategy Fund (RMQAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RYOIX | RMQAX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.14 | 0.67 | +0.47 |
Sortino ratioReturn per unit of downside risk | 1.64 | 1.28 | +0.36 |
Omega ratioGain probability vs. loss probability | 1.21 | 1.18 | +0.02 |
Calmar ratioReturn relative to maximum drawdown | 1.71 | 0.96 | +0.75 |
Martin ratioReturn relative to average drawdown | 6.79 | 3.36 | +3.43 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| RYOIX | RMQAX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.14 | 0.67 | +0.47 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.18 | 0.34 | -0.16 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.36 | 0.65 | -0.29 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.35 | 0.62 | -0.27 |
Correlation
The correlation between RYOIX and RMQAX is 0.62, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
RYOIX vs. RMQAX - Dividend Comparison
RYOIX's dividend yield for the trailing twelve months is around 12.93%, less than RMQAX's 44.79% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RYOIX Rydex Biotechnology Fund | 12.93% | 12.57% | 14.61% | 0.00% | 1.29% | 19.39% | 7.28% | 8.58% | 14.11% | 5.38% | 0.00% | 1.45% |
RMQAX Rydex Monthly Rebalance NASDAQ-100 2x Strategy Fund | 44.79% | 36.27% | 26.02% | 3.76% | 0.00% | 2.18% | 5.30% | 0.10% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
RYOIX vs. RMQAX - Drawdown Comparison
The maximum RYOIX drawdown since its inception was -74.43%, which is greater than RMQAX's maximum drawdown of -63.18%. Use the drawdown chart below to compare losses from any high point for RYOIX and RMQAX.
Loading graphics...
Drawdown Indicators
| RYOIX | RMQAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.43% | -63.18% | -11.25% |
Max Drawdown (1Y)Largest decline over 1 year | -12.10% | -25.11% | +13.01% |
Max Drawdown (5Y)Largest decline over 5 years | -33.66% | -63.18% | +29.52% |
Max Drawdown (10Y)Largest decline over 10 years | -33.66% | -63.18% | +29.52% |
Current DrawdownCurrent decline from peak | -7.52% | -24.96% | +17.44% |
Average DrawdownAverage peak-to-trough decline | -27.81% | -13.05% | -14.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.65% | 7.20% | -3.55% |
Volatility
RYOIX vs. RMQAX - Volatility Comparison
The current volatility for Rydex Biotechnology Fund (RYOIX) is 6.76%, while Rydex Monthly Rebalance NASDAQ-100 2x Strategy Fund (RMQAX) has a volatility of 11.12%. This indicates that RYOIX experiences smaller price fluctuations and is considered to be less risky than RMQAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| RYOIX | RMQAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.76% | 11.12% | -4.36% |
Volatility (6M)Calculated over the trailing 6-month period | 13.23% | 25.22% | -11.99% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.95% | 47.33% | -24.38% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.08% | 46.16% | -25.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.33% | 46.29% | -22.96% |